Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.11.2022 | Case report

CAR-T-cell-therapies/immunosuppressants

Human herpesvirus 6 encephalitis: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Rebechi MT, et al. HHV-6 Encephalitis after Chimeric Antigen Receptor T-cell Therapy (CAR-T): 2 Case Reports and a Brief Review of the Literature. Open Forum Infectious Diseases 8: No. 11, Nov 2021. Available from: URL: http://doi.org/10.1093/ofid/ofab470 Rebechi MT, et al. HHV-6 Encephalitis after Chimeric Antigen Receptor T-cell Therapy (CAR-T): 2 Case Reports and a Brief Review of the Literature. Open Forum Infectious Diseases 8: No. 11, Nov 2021. Available from: URL: http://​doi.​org/​10.​1093/​ofid/​ofab470
Metadaten
Titel
CAR-T-cell-therapies/immunosuppressants
Human herpesvirus 6 encephalitis: 2 case reports
Publikationsdatum
01.11.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-28499-7

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Multiple drugs

Case report

Methotrexate